BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14605213)

  • 21. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism.
    Podda MV; Riccardi E; D'Ascenzo M; Azzena GB; Grassi C
    Neuroscience; 2010 May; 167(3):678-90. PubMed ID: 20211700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
    Olianas MC; Dedoni S; Onali P
    Neurochem Int; 2012 Dec; 61(8):1404-16. PubMed ID: 23073238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones.
    Fan SF; Yazulla S
    Vis Neurosci; 2004; 21(1):69-77. PubMed ID: 15137583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of protein kinase A prevents the ethanol-induced up-regulation of delta-opioid receptor mRNA in NG108-15 cells.
    Jenab S; Inturrisi CE
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):44-8. PubMed ID: 9221900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a signaling cascade that maintains constitutive δ-opioid receptor incompetence in peripheral sensory neurons.
    Brackley AD; Sarrami S; Gomez R; Guerrero KA; Jeske NA
    J Biol Chem; 2017 May; 292(21):8762-8772. PubMed ID: 28381559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons.
    Zhang X; Nagai T; Ahammad RU; Kuroda K; Nakamuta S; Nakano T; Yukinawa N; Funahashi Y; Yamahashi Y; Amano M; Yoshimoto J; Yamada K; Kaibuchi K
    Neurochem Int; 2019 Jan; 122():8-18. PubMed ID: 30336179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.
    Franklin JM; Carrasco GA
    J Psychopharmacol; 2012 Oct; 26(10):1333-47. PubMed ID: 22791651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensing Positive versus Negative Reward Signals through Adenylyl Cyclase-Coupled GPCRs in Direct and Indirect Pathway Striatal Medium Spiny Neurons.
    Nair AG; Gutierrez-Arenas O; Eriksson O; Vincent P; Hellgren Kotaleski J
    J Neurosci; 2015 Oct; 35(41):14017-30. PubMed ID: 26468202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol.
    Constantinescu A; Gordon AS; Diamond I
    J Biol Chem; 2002 May; 277(21):18810-6. PubMed ID: 11886856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA.
    Liang J; Kruijssen DLH; Verschuuren ACJ; Voesenek BJB; Benavides FFW; Sáez Gonzalez M; Ruiter M; Wierenga CJ
    J Neurosci; 2021 Oct; 41(40):8279-8296. PubMed ID: 34413209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
    Sim-Selley LJ
    Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol.
    Coe IR; Dohrman DP; Constantinescu A; Diamond I; Gordon AS
    J Pharmacol Exp Ther; 1996 Feb; 276(2):365-9. PubMed ID: 8632298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumbal D2R-medium spiny neurons regulate aversive behaviors through PKA-Rap1 pathway.
    Lin YH; Yamahashi Y; Kuroda K; Faruk MO; Zhang X; Yamada K; Yamanaka A; Nagai T; Kaibuchi K
    Neurochem Int; 2021 Feb; 143():104935. PubMed ID: 33301817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
    Pan B; Hillard CJ; Liu QS
    J Neurosci; 2008 Dec; 28(52):14018-30. PubMed ID: 19109485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons.
    Carruthers AM; Sellers LA; Jenkins DW; Jarvie EM; Feniuk W; Humphrey PP
    Mol Pharmacol; 2001 Jun; 59(6):1533-41. PubMed ID: 11353815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cAMP-dependent protein kinase type I regulates ethanol-induced cAMP response element-mediated gene expression via activation of CREB-binding protein and inhibition of MAPK.
    Constantinescu A; Wu M; Asher O; Diamond I
    J Biol Chem; 2004 Oct; 279(41):43321-9. PubMed ID: 15299023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation.
    Mediero A; Perez-Aso M; Cronstein BN
    Br J Pharmacol; 2013 Jul; 169(6):1372-88. PubMed ID: 23647065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.